tucatinib 150 MG Oral Tablet [Tukysa]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

tucatinib 150 MG Oral Tablet [Tukysa]

150 MG · Oral Tablet · oral

A form of tucatinib →

tucatinib 150 MG Oral Tablet [Tukysa] — Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors. Strength, form, class, interactions & more.

tucatinib 150 MG Oral Tablet [Tukysa]

Active ingredient

tucatinib →

Classification

Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitorsKinase Inhibitor

Drug interactions

Tucatinib has several drug interactions that may affect its plasma concentrations and the concentrations of other drugs.

  • majorstrong CYP3A inducers — decreased tucatinib plasma concentrations
  • majormoderate CYP2C8 inducers — decreased tucatinib plasma concentrations
  • majorstrong CYP2C8 inhibitors — increased tucatinib plasma concentrations
  • majorCYP3A substrates — increased plasma concentrations of CYP3A substrate
  • majorP-gp substrates — increased plasma concentrations of P-gp substrate

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.

Get started freeSee how Eleplan works →